Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells

References

• WHO. WHO | Cancer Factsheet. WHO. 2017. doi:/entity/mediacentre/factsheets/fs297/en/index.html.
   Google Scholar
• WHO. Latest world cancer statistics Global cancer burden rises to 14. 1 million new cases in 2012 : Marked increase in breast cancers must be addressed. International Agency for Research on Cancer, World Health Organization. 2013;(December):2012–2014. http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf.
   Google Scholar
• Mahendra P, Bisht S. Ferula asafoetida: Traditional uses and pharmacological activity. Phcog Rev. 2012;6(12):141–6. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3459456&tool=pmcentrez&rendertype=abstract. doi:10.4103/0973-7847.99948
   Google Scholar
• Salim LZA, Mohan S, Othman R, Abdelwahab SI, Kamalidehghan B, Sheikh BY, Ibrahim MY. Thymoquinone induces mitochondria-mediated apoptosis in acute lymphoblastic leukaemia in vitro. Molecules. 2013;18(9):11219–40. doi:10.3390/molecules180911219
   PubMed Web of Science ®Google Scholar
• Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. Oncotarget. 2015;6(23). doi:10.18632/oncotarget.3973
   Google Scholar
• Yi T, Cho S-G, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Therap. 2008;7(7):1789–96. doi:10.1158/1535-7163.MCT-08-0124
   PubMed Web of Science ®Google Scholar
• Attoub S, Sperandio O, Raza H, Arafat K, Al-Salam S, Al Sultan MA, Al Safi M, Takahashi T, Adem A. Thymoquinone as an anticancer agent: Evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam Clin Pharmacol. 2013;27(5):557–69. doi:10.1111/j.1472-8206.2012.01056.x
   PubMed Web of Science ®Google Scholar
• Baskaran N, Manoharan S, Balakrishnan S, Pugalendhi P. Chemopreventive potential of ferulic acid in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats. Eur J Pharmacol. 2010;637(1–3):22–9. doi:10.1016/j.ejphar.2010.03.054
   PubMed Web of Science ®Google Scholar
• Peng L, Liu A, Shen Y, Xu HZ, Yang SZ, Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, et al. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway. Oncol Rep. 2013;29(2):571–8. doi:10.3892/or.2012.2165
   PubMed Web of Science ®Google Scholar
• Dodurga Y, Eroğlu C, Seçme M, Elmas L, Avcı ÇB, Şatıroğlu-Tufan NL. Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP. Tumor Biol. 2016;37(2):1933–40. doi:10.1007/s13277-015-3984-z
   PubMedGoogle Scholar
• Wang T, Gong X, Jiang R, Li H, Du W, Kuang G. Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. Am J Transl Res. 2016;8(2):968–80.
   PubMed Web of Science ®Google Scholar
• Racoma IO, Meisen WH, Wang QE, Kaur B, Wani AA. Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One. 2013;8(9):e72882. doi:10.1371/journal.pone.0072882
   PubMed Web of Science ®Google Scholar
• Wang D, Wang Z, Tian B, Li X, Li S, Tian Y. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs. Int J Urol. 2008;15(5):435–41. doi:10.1111/j.1442-2042.2008.02025.x
   PubMed Web of Science ®Google Scholar
• Chen L, Ye HL, Zhang G, Yao WM, Chen XZ, Zhang FC, Liang G. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells. PLoS One. 2014;9(1):e85771. doi:10.1371/journal.pone.0085771
   PubMed Web of Science ®Google Scholar
• Soica C, Oprean C, Borcan F, Danciu C, Trandafirescu C, Coricovac D, Crăiniceanu Z, Dehelean C, Munteanu M. The synergistic biologic activity of oleanolic and ursolic acids in complex with hydroxypropyl-?-cyclodextrin. Molecules. 2014;19(4):4924–40. doi:10.3390/molecules19044924
   PubMed Web of Science ®Google Scholar
• Kundu J, Choi BY, Jeong CH, Kundu JK, Chun KS. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src-mediated phosphorylation of EGF receptor tyrosine kinase. Oncol Rep. 2014;32(2):821–8. doi:10.3892/or.2014.3223
   PubMed Web of Science ®Google Scholar
• Richards LR, Jones P, Hughes J, Benghuzzi H, Tucci M. The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the lncap cell line. Biomed Sci Instrum. 2006;42:357–62.
   PubMedGoogle Scholar
• Ganji-Harsini S, Khazaei M, Rashidi Z, Ghanbari A. Thymoquinone could increase the efficacy of tamoxifen induced apoptosis in human breast cancer cells: An in vitro study. Cell J. 2016;18(2):245–54. doi:10.22074/cellj.2016.4320
   PubMed Web of Science ®Google Scholar
• Gurung RL, Lim SN, Khaw AK, Soon JFF, Shenoy K, Ali SM, Jayapal M, Sethu S, Baskar R, Prakash Hande M. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS One. 2010;5(8):e12124. doi:10.1371/journal.pone.0012124
   PubMed Web of Science ®Google Scholar
• Xu D, Ma Y, Zhao B, Li S, Zhang YU, Pan S, Wu Y, Wang J, Wang D, Pan H, et al. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol Rep. 2014;31(5):2063–70. doi:10.3892/or.2014.3059
   PubMed Web of Science ®Google Scholar
• Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, Menon M, Dou QP, Reddy G-V. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res. 2007;67(16):7782–8. doi:10.1158/0008-5472.CAN-07-1483
   PubMed Web of Science ®Google Scholar
• Woo CC, Loo SY, Gee V, Yap CW, Sethi G, Kumar AP, Benny Tan KH. Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway. Biochem Pharmacol. 2011;82(5):464–75. doi:10.1016/j.bcp.2011.05.030
   PubMed Web of Science ®Google Scholar
• Zhang X, Lin D, Jiang R, Li H, Wan J, Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol Rep. 2016;36(1):271–8. doi:10.3892/or.2016.4804
   PubMed Web of Science ®Google Scholar
• Kampa M, Alexaki V-I, Notas G, Nifli A-P, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 2004;6(2):R63. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=400651 &tool=pmcentrez&rendertype=abstract%5Cn http://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr752.
   PubMed Web of Science ®Google Scholar
• Fahrioğlu U, Dodurga Y, Elmas L, Seçme M. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro. Gene. 2016;576(1):476–82. doi:10.1016/j.gene.2015.10.061
   PubMed Web of Science ®Google Scholar
• Gerige SJ, Gerige MKY, Rao M. Ramanjaneyulu GC-MS analysis of Nigella sativa seeds and antimicrobial activity of its volatile oil. Brazilian Arch Biol Technol. 2009;52(5):1189–1192. doi:10.1590/S1516-89132009000500016
   Web of Science ®Google Scholar
• Vijayalakshmi Adiga S, Bhat P, Chaturvedi A, Bairy KL, Kamath S. Evaluation of the effect of Ferula asafoetida Linn. gum extract on learning and memory in Wistar rats. Indian J Pharmacol. 2012;44(1):82. doi:10.4103/0253-7613.91873
   PubMed Web of Science ®Google Scholar